Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Zafari J et al. | 2024 | intact cell/cell culture, A2780 (human ovarian carcinoma-sensitive to cisplatin) and A2780-CP (human ovarian carcinoma-resistant to cisplatin) | static magnetic field, also other exposures without EMF, co-exposure | - |
Xue X et al. | 2020 | intact cell/cell culture, BEAS-2B (human bronchial epithelial cells) | geomagnetic field, shielding/field deprivation, also other exposures without EMF, co-exposure | - |
Okonogi H et al. | 1996 | intact cell/cell culture, CHL/IU (Chinese hamster lung cells) | static magnetic field, co-exposure | 4.75 T |
Rekena A et al. | 2021 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | static magnetic field | - |
Wolff S et al. | 1985 | intact cell/cell culture, CHO (Chinese hamster ovary) cells and human lymphocytes | RF, static magnetic field, MRI | 2.35 T |
Nakahara T et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells | static magnetic field, DC, co-exposure | 1–10 T |
Rossner P et al. | 1977 | intact cell/cell culture, Chinese hamster lung cells | static magnetic field, DC, co-exposure | 140 mT |
Volpe P et al. | 2005 | intact cell/cell culture, Friend erythroleukemia cell line | geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Schwenzer NF et al. | 2007 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) and KG1a (human acute myeloid leukaemia cells) | static magnetic field, MRI | 3 T |
Raylman RR et al. | 1996 | intact cell/cell culture, HTB 63 (melanoma cells), HTB 77 IP3 (ovarian carcinoma cells) and CCL 86 (lymphoma cells) | static magnetic field | 7 T |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.